The parent company of Da Vinci Robots
There should be no one who does not know about the Da Vinci medical surgical robot, right? Da Vinci Medical Surgical Robot is now more famous than this company. I mentioned this company in the preface of my book “The Rules of Super Growth Stocks Investing”.
It’s already subscription
The Da Vinci medical surgical robot, the cheapest one (please note that I use the word cheapest model) costs $1.5 million. This looks like a good deal, doesn’t it? But intuitive surgery find ways to make more money. After Da Vinci’s medical surgical robot is sold to you, you will be charged for follow-up training, maintenance, and consumables; this is amazing. An estimated $500,000 per year. In particular, all its consumables are designed to be used only once, and after one surgery is opened, all of them have to be replaced.
How is the performance?
Here’s how Intuitive Surgery performed in 2021:
|Da Vinci medical surgical robot installed numbers||6,730|
2021’s annual report
|US$ million||Annual growth rate|
|Gross margin rate||69%||+300 bps|
It has been listed for 22 years, and the revenue growth rate can still be 31%!
What about competitors?
It would be an overstatement to say that it has no competition. However, intuition surgery is a medical devices company that focuses on medical surgical robot only. The other major competitors are all veterans who have been in the medical field for a long time. All of them have a lot of background. They have almost unlimited resources and abundant connections in medical institutions. Everyone is eyeing the achievements of intuitive surgery. Take it for nothing.
The versatile Da Vinci robot
Medical surgical robots basically have functional limitations, or only specialize in a certain field, and there is no all-round medical surgical robot. The Da Vinci robot is no exception, but it should be the most versatile surgical robot, which means that it can perform the most types of surgical operations approved by the FDA. Officially documented in company documents, there are at least 10 major categories of approved surgeries.
The King of patent
Intuitive Surgery has a total of over 4,200 U.S. and foreign patents licensed in the field and has filed over 2,100 U.S. and foreign patent applications to date. This is due to the fact that when the company was founded, it was a technology-oriented company, focusing on patents. Without patent protection, products would be counterfeited immediately.
How is the valuation?
The following table shows the valuation of intuitive surgery by market as of 03/15/2022:
|Market capitalization||US$ 96.983 billion|
This valuation level is no different from that of “top” technology companies, and it is higher than that of the top five technology stocks. You might think it’s too expensive. In my own experience of tracking it for more than 20 years, the stock of this company has never been cheap, and the price-earnings ratio is rarely below 50.
How is the share price performing?
Since the beginning of 2022, the US stock market Nasdaq has entered a bear market, the broader market has entered a correction, and all stocks have plummeted across the board. Intuitive surgery is only down about 25%, and it’s one of the more resilient stocks, which is also reasonable. A recession or a stock market crash, or someone is sick, and they have to be treated with surgery.
Intuitive Surgery has undergone two stock splits since it went public; in 2017 and 2021, both of them are one-for-three splits. Since its listing in 2000, the stock has rised 13,200% as shown in the chart below.
The annualized return rate for 22 years is an astonishing 24.85%! During the same period, the annualized return of the S&P 500, which represents the U.S. stock market, was only 5.49%. Let’s take a look at its stock price chart, which is almost a perfect upward curve!
- The content of this site is the author’s personal opinions and is for reference only. I am not responsible for the correctness, opinions, and immediacy of the content and information of the article. Readers must make their own judgments.
- I shall not be liable for any damages or other legal liabilities for the direct or indirect losses caused by the readers’ direct or indirect reliance on and reference to the information on this site, or all the responsibilities arising therefrom, as a result of any investment behavior.